Exact Mass: 650.0616874

Exact Mass Matches: 650.0616874

Found 38 metabolites which its exact mass value is equals to given mass value 650.0616874, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3,4,5-trihydroxy-2-({3,4,5,11,12,13,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaen-21-yl}oxy)benzoic acid

C27H22O19 (650.0755262)

Bisnorbadioquinone A

2-[(2E)-4-{7-[(5Z)-5-[carboxy(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl]-3,4-dioxo-3,4-dihydronaphthalen-1-yl}-3-hydroxy-5-oxo-2,5-dihydrofuran-2-ylidene]-2-(4-hydroxyphenyl)acetic acid

C34H18O14 (650.0696528)

Bisnorbadioquinone A is found in mushrooms. Bisnorbadioquinone A is isolated from higher fungus Xerocomus badius (kostanjevka). Isolated from higher fungus Xerocomus badius (kostanjevka). Bisnorbadioquinone A is found in mushrooms.

Bisnorbadioquinone A

2-[(2Z)-4-{8-[(5E)-5-[carboxy(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl]-5,6-dioxo-5,6-dihydronaphthalen-2-yl}-3-hydroxy-5-oxo-2,5-dihydrofuran-2-ylidene]-2-(4-hydroxyphenyl)acetic acid

C34H18O14 (650.0696528)

(2-hydroxyethyl)dimethyl[3-[(3-sulphopropyl)[(tridecafluorohexyl)sulphonyl]amino]propyl]ammonium hydroxide

C16H23F13N2O6S2 (650.0789894)

1,1-Bis (di-t-butylphosphino)ferrocene palladium dichloride,

C26H44Cl2FeP2Pd (650.0679283999999)

(r)-(+)-5,5-dichloro-6,6-dimethoxy-2,2-bis(diphenylphosphino)-1,1-biphenyl

C38H30Cl2O2P2 (650.1098000000001)

disodium 3-[[4-amino-9,10-dihydro-3-[2-hydroxy-3-(sulphonatooxy)propoxy]-9,10-dioxo-1-anthryl]amino]-2,4,6-trimethylbenzenesulphonate

C26H24N2Na2O11S2 (650.0616874)

3,3-(Biphenyl-4,4-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate)

C32H22N6O6S2-2 (650.1042192)

rUrd-P-rAdo-P

C19H22N7O15P2-3 (650.0649102000001)

PI3K/AKT-IN-2

C32H27BrO10 (650.0787502000001)

PI3K/AKT-IN-2 (Compound 12c) is a PI3K and AKT inhibitor. PI3K/AKT-IN-2 blocks the epithelial-mesenchymal transition (EMT) and induces apoptosis. PI3K/AKT-IN-2 inhibits the polymerization of tubulin[1].

(1s,8r,9s,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,8r,9s,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(1s,7s,9s,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,7s,9s,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

3-[3,4,5,17,18,19-hexahydroxy-8,14-dioxo-11-(3,4,5-trihydroxybenzoyloxy)-9,13-dioxatricyclo[13.4.0.0²,⁷]nonadeca-1(19),2(7),3,5,15,17-hexaen-10-yl]-2,3-dihydroxypropanoic acid

C27H22O19 (650.0755262)

[4-(8-{5-[carboxy(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxofuran-3-yl}-5,6-dioxonaphthalen-2-yl)-3-hydroxy-5-oxofuran-2-ylidene](4-hydroxyphenyl)acetic acid

C34H18O14 (650.0696528)

(2r,3r)-3-[(10s,11r)-3,4,5,17,18,19-hexahydroxy-8,14-dioxo-11-(3,4,5-trihydroxybenzoyloxy)-9,13-dioxatricyclo[13.4.0.0²,⁷]nonadeca-1(19),2(7),3,5,15,17-hexaen-10-yl]-2,3-dihydroxypropanoic acid

C27H22O19 (650.0755262)

(1s,8r,9r,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,8r,9r,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

6,12-bis(6-bromo-1h-indol-3-yl)-11-hydroxy-2,9-diimino-1,3,8-trimethyl-1,3,8,10-tetraazadispiro[4.1.4⁷.1⁵]dodec-10-en-4-one

C27H24Br2N8O2 (650.0388843999999)

[(2e)-4-{7-[(5e)-5-[carboxy(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxofuran-3-yl]-3,4-dioxonaphthalen-1-yl}-3-hydroxy-5-oxofuran-2-ylidene](4-hydroxyphenyl)acetic acid

C34H18O14 (650.0696528)

7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(2r,3r)-3-[(10s,11s)-3,4,5,17,18,19-hexahydroxy-8,14-dioxo-11-(3,4,5-trihydroxybenzoyloxy)-9,13-dioxatricyclo[13.4.0.0²,⁷]nonadeca-1(19),2(7),3,5,15,17-hexaen-10-yl]-2,3-dihydroxypropanoic acid

C27H22O19 (650.0755262)

1,8,17,18,22,22-hexahydroxy-9-(hydroxymethyl)-2,5,14-trioxo-6,10,13,23-tetraoxapentacyclo[17.3.1.0⁴,²¹.0⁷,¹².0¹⁵,²⁰]tricosa-3,15,17,19-tetraen-11-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(7s,8r,9r,11s,12r,21r)-1,8,17,18,22,22-hexahydroxy-9-(hydroxymethyl)-2,5,14-trioxo-6,10,13,23-tetraoxapentacyclo[17.3.1.0⁴,²¹.0⁷,¹².0¹⁵,²⁰]tricosa-3,15,17,19-tetraen-11-yl 3,4,5-trihydroxybenzoate

(7s,8r,9r,11s,12r,21r)-1,8,17,18,22,22-hexahydroxy-9-(hydroxymethyl)-2,5,14-trioxo-6,10,13,23-tetraoxapentacyclo[17.3.1.0⁴,²¹.0⁷,¹².0¹⁵,²⁰]tricosa-3,15,17,19-tetraen-11-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(1s,7s,9r,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,7s,9r,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(1s,9r,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,9r,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(5r,6r,7r,12r)-6,12-bis(6-bromo-1h-indol-3-yl)-11-hydroxy-2,9-diimino-1,3,8-trimethyl-1,3,8,10-tetraazadispiro[4.1.4⁷.1⁵]dodec-10-en-4-one

C27H24Br2N8O2 (650.0388843999999)

3,4,5-trihydroxy-2-{[(10s,11r,12r,13r,15r)-3,4,5,11,12,13,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2(7),3,5,20,22-hexaen-21-yl]oxy}benzoic acid

C27H22O19 (650.0755262)

3,4,5-trihydroxy-2-({3,4,5,11,12,13,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2(7),3,5,20,22-hexaen-21-yl}oxy)benzoic acid

C27H22O19 (650.0755262)

(1s,8r,9r,18r,19s,21r,22r)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,8r,9r,18r,19s,21r,22r)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)

(1s,7r,9r,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

(1s,7r,9r,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate

C27H22O19 (650.0755262)